Liver abscess complicating transcatheter arterial embolization: A rare but serious complication. A retrospective study after 3878 procedures

European Journal of Gastroenterology and Hepatology

Volumn 16, Issue 8, 2004, Pages 737-742

  Ong, Guan Yeow ^a,b   Changchien, Chi Sin ^a   Lee, Chuan Mo ^a   Wang, Jing Houng ^a   Tung, Hung Da ^a   Chuah, Seng Kee ^a   Chiu, King Wah ^a   Chiou, Shue Shian ^a   Cheng, Yu Fan ^a   Lu, Sheng Nan ^a  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b Guo Ren Hospital   (Taiwan)

Author keywords

Fever pattern; Hepatocellular carcinoma (HCC); Liver abscess; Transcatheter arterial embolization (TAE)

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL PAIN; ABSCESS DRAINAGE; ADULT; AGED; ARTIFICIAL EMBOLISM; BLOOD EXAMINATION; CHILL; CLINICAL FEATURE; DEMOGRAPHY; FEMALE; FEVER; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; LIVER ABSCESS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; EMBOLIZATION, THERAPEUTIC; FEMALE; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LIVER ABSCESS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 4043113629     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.meg.0000108361.41221.8c     Document Type: Review

References (28)

1. Chung JW, Park JH, Han JK, Choi BI, Han MC, Lee HS, Kim CY. Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology 1996; 198:33-40.
2. Hemingway AP, Allison DJ. Complications of embolization: analysis of 410 procedures. Radiology 1988; 166:669-672.
3. Wong E, Khardori N, Carrasco CH, Wallace S, Patt Y, Bodey GP. Infectious complications of hepatic artery catheterization procedures in patients with cancer. Rev Infect Dis 1991; 13:583-586.
4. Gates J, Hartnell GG, Stuart KE, Clouse ME. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999; 19:399-414.
5. Takayasu K, Moriyama N, Muramatsu Y, Suzuki M, Ishikawa T, Ushio K, et al. Splenic infarction, a complication of transcatheter hepatic arterial embolization for liver malignancies. Radiology 1984; 151:371-375.
6. Allison DJ, Jordon H, Henessy O. Therapeutic embolization of the hepatic artery: a review of 75 procedures. Lancet 1985; i:595-599.
7. Cheng YF, Kan Z, Chen CL, Huang TL, Chen TY, Yang BY, et al. Efficacy and safety of preoperative lobar or segmental ablation via transarterial administration of ethiodol and ethanol mixture for treatment of hepatocellular carcinoma: clinical study. World J Surg 2000; 24:844-850.
8. De Baere T, Roche A, Amenabar JM, Lagrange C, Ducreux M, Rougier P, et al. Liver abscess formation after local treatment of liver tumors. Hepatology 1996; 23:1436-7440.
9. Chen C, Tsang YM, Hsueh PR, Huang GT, Yang PM, Sheu JC, et al. Bacterial infections associated with hepatic arteriography and transarterial embolization for hepatic cellular carcinoma: a prospective study. Clin Infec Dis 1999; 29:161-166.
10. Song SY, Chung JW, Han JK, Lim HG, Koh YH, Park JH, et al. Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome. J Vasc Interv Radiol 2001; 12:313-320.
11. Kim W, Clark TW, Baum RA, Soulen MC. Risk factors for liver abscess formation after hepatic chemoembolization. J Vasc Interv Radiol 2001; 12:965-968.
12. Chen C, Chen PJ, Yang PM, Huang GT, Lai MY, Tsang YM, Chen DS. Clinical and microbiological features of liver abscess after transarterial embolization for hepatocellular carcinoma. Am J Gastroenterol 1997; 92:2257-2259.
13. Inoue H, Hori A, Satake M, Kanetsuki I, Ueno K, Nishida H, et al. Liver abscess formation after treatment of liver cancer by arterial injection using adriamycin/mitomycin C oil suspension (ADMOS). Nippon Acta Radiologica 1992; 52:155-163.
14. Hashimoto T, Mitani T, Nakamura H, Hori S, Kozuka T, Kobayashi Y, et al. Fatal septic complication of transcatheter chemoembolization for hepatocellular carcinoma. Cardiovasc Interv Radiol 1993; 16:325-327.
15. Eckel F, Lersch C, Huber W, Weiss W, Berger H, Schulte-Frohlinde E. Multimicrobial sepsis including Clostridium perfringens after chemoembolization of a single liver metastasis from common bile duct cancer. Digestion 2000; 62:208-212..
16. Chung JW, Park JH, Han JK, Choi BI, Han MC. Hepatocellular carcinoma and portal vein invasion: results of treatment with transcatheter oily chemoembolization. Am J Roentgenol 1995; 165:315-321.
17. Reed RA, Teltelbaum GP, Daniels JR, Pentecost MJ, Katz MD. Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics. J Vasc Interv Radiol 1994; 5:367-371.
18. Shawker TH, Kluge RM, Ayella RJ. Bacteremia associated with angiography. JAMA 1974; 229:1090-1092.
19. Koizumi J, Kodera K, Kaneda S. Liver abscess as a complication of TAE - risk factors and prevention. Nippon Acta Radiologica 1990; 50:592-598.
20. Doppman JL, Girton M, Vermess M. The risk of hepatic artery embolization in the presence of obstructive jaundice. Radiology 1982; 143:37-43.
21. Sternlicht M, Daniels JR, Sales SF, Daniels AM. Effects of antimicrobial protection on tolerance to hepatic chemoembolization with a fibrous collagen carrier. Radiology 1989; 170:1067-1071.
22. Chuah SK, Tai DI, Changchien CS, Lin DY, Chiu KW, Chen JJ. Long term survival of a patient with a regressed giant hepatocellular carcinoma after transcatheter hepatic artery embolization (TAE) complicated with liver abscess. Chang Gung Med J 1994; 17:68-73.
23. Coley WB. Contribution to the knowledge of sarcoma. Ann Surg 1981; 14:199-200.
24. Morton DL, Eilber FR, Holmes EC, Hunt JS, Ketchan AS, Silversteiu MJ, Sparks FC. BCG immunotherapy of malignant melanoma: summary of a seven-year experience. Ann Surg 1973; 180:635-643.
25. Hung GT, Yang PC, Sheu JC, Hsu HC, Sung JL, Wang TH, Chen DS. Intratumor injection of OK-432 for the treatment of small hepatocellular carcinoma. Hepato-gastroenterol 1990; 37:439-532.
26. Bermudes D, Low B, Pawelek J. Tumor-targeted Salmonella. Highly selective delivery vectors. Adv Exp Med Biol 2000; 465:57-63.
27. Bermudes D, Zheng LM, King IC. Live bacteria as anticancer agents and tumor-selective protein delivery vectors. Curr Opin Drug Discov Devel 2002; 5:194-199.
28. Hawkins LK, Lemoine NR, Kim D. Oncolytic biotherapy: a novel therapeutic platform. Lancet Oncol 2002; 3:17-26.